Target intelligence / Profile preview

Olfactory receptor family 5 subfamily H member 15 (OR5H15)

Target
OR5H15
Molecular classification
G protein-coupled receptor (GPCR), Receptor, Olfactory receptor
01

Overview

Olfactory receptor family 5 subfamily H member 15 (OR5H15) is a member of the large family of olfactory receptors, which are G protein-coupled receptors characterized by a seven-transmembrane domain structure[4][9]. These receptors are expressed predominantly in the olfactory epithelium of the nose, where they recognize and bind various odorant molecules, initiating a G protein-mediated signal transduction cascade that ultimately triggers the perception of smell[3][4]. The olfactory receptor gene family is the largest in the human genome, with each receptor thought to interact with a range of odorants to create the diversity of human olfactory perception[8][9]. There is no current evidence of OR5H15 functioning as a therapeutic target, or being associated with specific diseases, biomarkers, or therapeutic drugs[8][9]. The main biological role is chemosensory function in the olfactory system.

Other names
OR5H15Olfactory receptor 5H15O5H15
02

Mechanism of action

Not applicable or unknown (There are no therapeutic drugs with known mechanisms targeting OR5H15. For the olfactory receptor family, the physiological mechanism is G-protein-coupled signal transduction in response to odorant binding, not pharmacological targeting[3][4].)

03

Biological functions

Signal transduction (in response to odorants)Recognition of odorant molecules (chemicals that contribute to smell)Initiation of neuronal signaling in olfactory sensory neurons
04

Disease associations

There is no specific disease association reported for OR5H15; however, the olfactory receptor family broadly has been implicated in some non-olfactory physiological functions and possibly in diseases when dysregulated.
05

Safety considerations

None (No known safety or therapeutic challenges specific to this target, since it is not a clinical or therapeutic target[8][9].)
06

Interacting drugs

None reported (No drugs are known to target OR5H15 directly as a therapeutic agent; olfactory receptors in general are not common drug targets, and there are no well-documented interacting drugs for this specific receptor[8][9].)
07

Biomarkers

None (OR5H15 is not used as a biomarker for patient selection or efficacy monitoring[9].)

Beyond the preview

Go deeper on Olfactory receptor family 5 subfamily H member 15 (OR5H15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 5 subfamily H member 15 (OR5H15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call